Impaired 𝜷 Cell Function in Chinese Newly Diagnosed Type 2 Diabetes Mellitus with Hyperlipidemia

Table 1

Demographic and clinical data between newly diagnosed T2DM with and without hyperlipidemia.

	Newly diagnosed T2DM; with hyperlipidemia	Newly diagnosed T2DM; without hyperlipidemia
𝑁 (M/F)	132 (76/56)	76 (44/32)
Age (years)	53.41 ± 11.97*	57.10 ± 11.77
Diabetic duration (months)	2.09 ± 1.64	2.01 ± 1.38
BMI (kg/m^2)	25.45 ± 3.25	24.67 ± 3.52
TG (mmol/L)	2.38 ± 1.30**	1.21 ± 0.29
TCH (mmol/L)	5.50 ± 1.08**	4.26 ± 0.61
HDL-C (mmol/L)	1.17 ± 0.28	1.18 ± 0.28
LDL-C (mmol/L)	3.52 ± 1.10**	2.57 ± 0.70
FPG (mmol/L)	9.60 ± 2.73	8.84 ± 3.49
2hPG (mmol/L)	17.20 ± 4.61	16.06 ± 5.64
FINS (pmol/L)	59.41 ± 30.99	60.73 ± 43.10
2hINS (pmol/L)	322.45 ± 325.11	353.96 ± 246.03
HbA1C (%)	9.31 ± 2.27	8.93 ± 2.76

Data are expressed as mean ± SD.
BMI: body mass index; TCH: total cholesterol; TG: triglyceride; HDL-C: high density lipoprotein-cholesterol; LDL-C: low density lipoprotein-cholesterol; FPG: fasting plasma glucose; 2hPG: 2h postprandial glucose; FINS: fasting insulin; 2hINS: 2h postprandial serum insulin; HbA1c: hemoglobin A1c.
Hyperlipidemia was defined as serum cholesterol was over 5.2 mmol/L or/and serum triglyceride was over 1.7 mmol/L. *𝑃<0.05 versus newly diagnosed T2DM without hyperlipidemia; **𝑃<0.01 versus newly diagnosed T2DM without hyperlipidemia.